基本信息
views: 1649
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mrs. Lisa Wang has been the sole Biostatistician for the Princess Margaret Hospital Consortium (PMHC) over the past 11 years, which has led more than 100 early-phase academic trials in Canada. Many of these studies incorporate novel endpoints, designs, assessment and validation of innovative therapeutic strategies for cancer, including molecular targeted therapies. She was the Chair of Data Safety Monitor Board (DSMB) of PMHC from 2007-2016 and a member of the PMCC DSMB from 2007-2013. Her primary research interests are early-phase clinical trial design, time-to-event analysis, longitudinal and missing data analysis. She is a first and co-author of more than 100 publications, in major statistical, medical research book chapters and journals.
Research Interests
Papers共 370 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologistsno. 3 (2024): 275-283
Cited0Views0Bibtex
0
0
Targeted oncologypp.1-11, (2024)
International Transfer Pricing Journalno. 2 (2024)
Cancer medicine (2023)
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 603-603
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 11560-11560
Load More
Author Statistics
#Papers: 371
#Citation: 10364
H-Index: 54
G-Index: 93
Sociability: 8
Diversity: 3
Activity: 88
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn